Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Scientists discover ethnic differences in immune response to TB bacterium

The immune response to the bacterium that causes tuberculosis (TB) varies between patients of different ethnic origin, raising important implications for the development of tests to diagnose and monitor treatment for the disease, according to new research published today in the journal PLOS Pathogens.

The study, led by researchers at Queen Mary, University of London, in collaboration with the Medical Research Council's National Institute for Medical Research (NIMR),analysed the immune response of 128 newly-diagnosed TB patients in London who were divided by ethnicity into those of African (45), European (27), Asian (55) or mixed European/Asian (1) ancestry.

TB is an infection caused by the TB bacterium Mycobacterium tuberculosis. It commonly affects the lungs. While it grew rare in the UK due to BCG vaccination, improvements in living standards and the introduction of effective antibiotic treatment, it has been on the increase since the late 1980s. TB also remains a major global health problem, responsible for nearly nine million new cases and 1.4million deaths in 2011.

By analysing the levels of various inflammatory markers in blood samples taken before treatment, the scientists showed that immune responses of Asians and Europeans were similar to each other, but different from those of Africans. This difference was caused by ethnic variation in the patients' genetic make-up and was not related to the strain of TB bacterium that the patients were infected with.

Dr Adrian Martineau, Reader in Respiratory Infection and Immunity at the Blizard Institute, part of Queen Mary, who led the research, said: "The TB bacterium has co-evolved with humans following migration to Europe and Asia some 70,000 years ago, and different strains of the TB bacterium disproportionately infect particular ethnic groups. Experiments with white blood cells cultured in the lab have shown that different strains of the TB bacterium elicit different amounts of inflammation. One might therefore expect that TB patients' immune responses would differ according to the strain of TB bacterium that they are infected with.

"However our study has shown, for the first time, that it is actually ethnic differences in the patient's genetic make-up that cause most of this variation in immune responses – with little effect of the TB strain they are infected with."

By analysing blood samples taken from 85 of the original cohort after an eight-week period of intensive treatment, the researchers found that ethnic variation in immune responses became even more marked. A number of immunological biomarkers, which correlated with either fast or slow clearance of the TB bacteria, were identified and found to differ between Africans and Europeans/Asians.

Dr Anna Coussens, who measured immune responses in patient samples at NIMR, said: "These findings have important implications, both for the development of new diagnostic tests, which increasingly rely on analysing the immune response, and also for work to identify candidate biomarkers to measure response to anti-TB treatment. In the future, diagnostic tests and biomarkers will need to be validated in different ethnic populations."

A key factor in determining the ethnic variation identified in the study appears to be the patients' genetic type of vitamin D binding protein – a molecule which binds vitamin D in the circulation.

Dr Martineau said: "There are different genetic types of this protein which vary in frequency between ethnic groups, adding to the growing evidence that vitamin D and the way it is carried in the blood is crucial in determining how a patient's immune system will respond to TB."

Further studies in other populations are now needed to validate the ethnic difference identified.

This work was funded by the British Lung Foundation and the Medical Research Council (MRC).

Dr John Moore-Gillon, Honorary Medical Adviser at the British Lung Foundation, which co-funded the research, said:

"Targeted therapies have long been talked about as the future of medicine. However, in order to develop such treatments, you first need to understand the ways in which the genetic makeup of different people can affect how a disease develops in, and affects, the body. This new research makes great strides forward in doing this for TB, highlighting for the first time how using different approaches for people of differing ethnic backgrounds can help improve our ability to diagnose the disease and monitor the effectiveness of any subsequent treatment.

"TB is a growing problem in the UK. With TB bacteria being notoriously difficult to identify and eradicate from the body, research such as this, that helps improve diagnosis and treatment of the disease, will be vital if we are to keep on top of the battle against its spread."

Tuberculosis (TB) is a bacterial infection. The most common type of TB is in the lungs, known as pulmonary TB. While TB can affect any part of the body, only TB of the lungs or throat is infectious.

Before antibiotics were introduced, TB was a major health problem in the UK. While the condition is much less common now it has gradually increased over the last 20 years, particularly among ethnic minority communities who are originally from places where TB is more common.

In 2011, 8,963 cases of TB were reported in the UK, with more than 6,000 of these cases affecting people who were born outside the UK.

Katrina Coutts | EurekAlert!
Further information:

More articles from Life Sciences:

nachricht Don't Give the Slightest Chance to Toxic Elements in Medicinal Products
23.03.2018 | Physikalisch-Technische Bundesanstalt (PTB)

nachricht North and South Cooperation to Combat Tuberculosis
22.03.2018 | Universität Zürich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Space observation with radar to secure Germany's space infrastructure

Satellites in near-Earth orbit are at risk due to the steady increase in space debris. But their mission in the areas of telecommunications, navigation or weather forecasts is essential for society. Fraunhofer FHR therefore develops radar-based systems which allow the detection, tracking and cataloging of even the smallest particles of debris. Satellite operators who have access to our data are in a better position to plan evasive maneuvers and prevent destructive collisions. From April, 25-29 2018, Fraunhofer FHR and its partners will exhibit the complementary radar systems TIRA and GESTRA as well as the latest radar techniques for space observation across three stands at the ILA Berlin.

The "traffic situation" in space is very tense: the Earth is currently being orbited not only by countless satellites but also by a large volume of space...

Im Focus: Researchers Discover New Anti-Cancer Protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.

The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

New solar solutions for sustainable buildings and cities

23.03.2018 | Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

Latest News

For graphite pellets, just add elbow grease

23.03.2018 | Materials Sciences

Unique communication strategy discovered in stem cell pathway controlling plant growth

23.03.2018 | Agricultural and Forestry Science

Sharpening the X-ray view of the nanocosm

23.03.2018 | Physics and Astronomy

Science & Research
Overview of more VideoLinks >>>